Exelixis (EXEL) Tax Provisions (2010 - 2026)
Exelixis' (EXEL) quarterly Tax Provisions came in at $57.2 million in Q2 2026, up 24.19% year-on-year from $46.1 million in Q2 2025, and up 601.23% quarter-over-quarter from $8.2 million in Q1 2026.
Exelixis (EXEL) Tax Provisions (2010 - 2026) Analysis & Trends
Exelixis' Tax Provisions history runs 14 years deep, the most recent figure standing at $57.2 million for Q2 2026.
- On a quarterly basis, Tax Provisions rose 24.19% year-over-year to $57.2 million in Q2 2026; TTM through Apr 2026 was $169.8 million, a 12.71% decrease from a year earlier, with the FY2026 full-year figure at $158.6 million, down 1.08% from the prior year.
- Tax Provisions advanced to $57.2 million in Q2 2026 per EXEL's latest filing, from $8.2 million in the prior quarter.
- Across five years, Tax Provisions topped out at $66.7 million in Q2 2024 and bottomed at -$1.3 million in Q4 2022.
- The 5-year median for Tax Provisions is $18.8 million (2022), against an average of $28.1 million.
- Across the five-year window, Tax Provisions tumbled 105.49% in 2022 and surged 1497.21% in 2023, its largest moves.
- Year by year, Tax Provisions stood at -$1.3 million in 2022, then jumped by 1497.21% to $17.5 million in 2023, then soared by 109.93% to $36.8 million in 2024, then soared by 59.96% to $58.8 million in 2025, then declined by 2.74% to $57.2 million in 2026.
- Per Business Quant, the three latest EXEL Tax Provisions figures stand at $57.2 million (Q2 2026), $8.2 million (Q1 2026), and $58.8 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 31.86 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 179.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Exelixis | 14.38 Bn | 13.60 Bn | 590.86 Mn | 57.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 57.22 Mn |
| Jan 2, 2026 | 8.16 Mn |
| Oct 3, 2025 | 58.84 Mn |
| Jul 4, 2025 | 45.57 Mn |
| Apr 4, 2025 | 46.07 Mn |
| Jan 3, 2025 | 44.91 Mn |
| Sep 27, 2024 | 36.78 Mn |
| Jun 28, 2024 | 66.73 Mn |
| Mar 29, 2024 | 11.95 Mn |
| Dec 29, 2023 | 17.52 Mn |
| Sep 29, 2023 | 4.78 Mn |
| Jun 30, 2023 | 19.21 Mn |
| Mar 31, 2023 | 8.25 Mn |
| Dec 30, 2022 | -1.25 Mn |
| Sep 30, 2022 | 18.83 Mn |
| Jul 1, 2022 | 17.84 Mn |
| Apr 1, 2022 | 16.66 Mn |
| Dec 31, 2021 | 22.86 Mn |
| Oct 1, 2021 | 15.06 Mn |
| Jul 2, 2021 | 28.80 Mn |